Alphamab Oncology Reports Full Year 2023 Financial Results and Business Highlights

SUZHOU, China, March 29, 2024  — Alphamab Oncology reported financial results for the full year ended December 31, 2023, and highlighted recent progress and upcoming milestones. Dr. Ting Xu, Chairman and CEO of Alphamab Oncology, commented, “In 2023, Alphamab Oncology continued to focus on addressing clinical needs and adhere to differentiated innovation. With one product already in the market and

Read more